Cancer Research Institute Announces 2026 CLIP and Technology Impact Awards: Fueling the Next Generation of Immunotherapy Breakthroughs
admin The Cancer Research Institute (CRI), a global leader in advancing immunology research to conquer cancer,...
biotech
America’s Biotech Renaissance: Regional Hubs Emerge as Billions in Pharma Manufacturing Investment Reshape Economic Landscape
As pharmaceutical manufacturing investment experiences an unprecedented surge, a concerted effort from state and federal...
Cancer Research Institute Fuels Next-Generation Immunotherapy Discoveries with Major Investment in Early-Career Scientists
The Cancer Research Institute (CRI) has announced a significant expansion of its commitment to fostering...
Biopharma Sector Buzzes with Regulatory Breakthroughs, Patent Disputes, and Strategic Deals
The biopharmaceutical landscape has been particularly dynamic this week, marked by significant regulatory developments, high-stakes...
Unlocking Ancient Secrets: Dr. Aaron Whiteley Receives Prestigious CRI STAR Award
Dr. Aaron Whiteley, an Assistant Professor in the Department of Biochemistry at the University of...
Zenbexus Clearance Marks New Era for Bristol Myers Squibb’s Multiple Myeloma Franchise
The U.S. Food and Drug Administration (FDA) has granted clearance to Zenbexus, a novel protein-degrading...
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
Pharmaceutical giant Eli Lilly and Company has significantly escalated its multi-front battle against the widespread...
Boulevard starts up with $65M to pursue targeted autoimmune drugs
Boulevard Bio, a newly formed biotechnology startup, officially commenced operations on Wednesday, announcing a robust...
Ying Huang Appointed CEO of K2 Therapeutics, Spearheading a $50 Million Seed-Funded Venture to Globalize Chinese Biotech Innovation
Ying Huang, the esteemed former CEO who steered Legend Biotech to commercial triumph with the...
Epicrispr lands $90M to advance epigenetic editing drug for rare muscle disease
Epicrispr Biotechnologies, a burgeoning player in the genetic medicine landscape, has successfully closed a $90...
